Story thread · 3 reports / 3 sources
New precision medicine venture gives Syngenis added firepower
smh.com.au · 1d · first report
Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.